Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Study Results Show The Efficacy Of Improved Hydrogen Peroxide Against Important Healthcare-Associated Pathogens


News provided by

Clorox Professional Products Company

Oct 18, 2012, 11:00 ET

Share this article

Share toX

Share this article

Share toX

OAKLAND, Calif., Oct. 18, 2012 /PRNewswire-USNewswire/ -- A new study published in the November issue of Infection Control and Hospital Epidemiology (ICHE), the journal of the Society for Healthcare Epidemiology of America (SHEA), finds for the first time that improved hydrogen peroxide, the active ingredient found in products such as Clorox Healthcare™ Hydrogen Peroxide Cleaner Disinfectants, had a greater log-reduction of organisms at a one-minute contact time than standard hydrogen peroxide and quaternary ammonium compounds (QUATS).

Researchers from the University of North Carolina (UNC) at Chapel Hill evaluated two healthcare hydrogen peroxide products, referred to in the study as containing improved hydrogen peroxide as the active ingredient (at 1.4% H2O2 and 0.5% H2O2). Both products were compared to standard hydrogen peroxide (0.5%, 1.4%, 3%) and a QUAT, at a one-minute contact time.

All of the actives were tested for their efficacy against three of the most common pathogens found in hospitals: community-acquired methicillin-resistant Staphylococcus aureus strain (MRSA), vancomycin-resistant Enterococcus (VRE) and multi-drug resistant Acinetobacter baumannii (MDR A. baumannii). In all tests, the improved hydrogen peroxide active ingredient proved to have a greater log-reduction of organisms to standard hydrogen peroxide and a greater or similar log-reduction to the QUAT tested at a one-minute contact time. UNC scientists will also present the study in a poster session at IDWeek, an infectious disease and epidemiology conference in San Diego, Calif. on Friday, October 19 (abstract #935).

"These findings demonstrate that improved hydrogen peroxide is a new low-level disinfectant option that is low in toxicity, fast-acting and a suitable choice for regular use to help control the spread of pathogens on common hospital environmental surfaces," said Dr. William A. Rutala, Ph.D., M.P.H., the study's lead researcher, Director, Hospital Epidemiology, Occupational Health, and Safety Program at UNC Health Care System.

Introducing Improved Hydrogen Peroxide to Healthcare Settings

Prior to the development of improved hydrogen peroxide, standard hydrogen peroxide was not considered a practical disinfectant for hospital use due to its instability. However, scientific advances have been made to the formulation of hydrogen peroxide products to associated weaknesses such as instability, limited antimicrobial efficacy and long surface contact times.

Healthcare-associated infections (HAIs) from organisms such as those caused by MRSA, VRE and MDR A. baumannii are an ongoing problem for healthcare facilities as they are commonly found in hospitals, easily transmitted to patients and staff and can survive on environmental surfaces for days, or even months. One of the best prevention methods for helping to curb the spread of organisms that cause HAIs is regular environmental surface disinfection with an Environmental Protection Agency (EPA)-registered disinfectant.

"Our study found the improved hydrogen peroxide products were able to kill the pathogens tested in less than one minute, a contact time that is considerably less than the contact time of the QUAT product tested in this study," said David J. Weber, M.D., M.P.H., professor of medicine, pediatrics and epidemiology in the Schools of Medicine and Global Public Health at UNC-Chapel Hill.

Clorox Healthcare™ Hydrogen Peroxide Products Offer Fast, Facility-Wide Disinfection

Clorox's hydrogen peroxide healthcare products are ready-to-use and combine hydrogen peroxide with activators, stabilizers and surfactants to offer fast-acting solutions that are noncorrosive and compatible with many healthcare surfaces and medical equipment.

Clorox Healthcare™ Hydrogen Peroxide Cleaner Disinfectant Wipes and Spray are EPA-registered to kill 37 bacteria and viruses in 30 seconds to 1 minute, the fastest non-bleach disinfecting time available.[1]   The products are also EPA-registered to kill norovirus and all of the ESKAPE pathogens, the six organisms responsible for two-thirds of all HAIs: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumonia, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species.[2] 

"These Clorox® disinfectants offer healthcare professionals a better-value, non-bleach product specifically manufactured in sizing options to accommodate the cleaning and disinfecting scenarios within healthcare facilities," said Beata Grabowski, senior director of marketing, Clorox Professional Products Company. "Clorox Healthcare™ Hydrogen Peroxide Cleaner Disinfectants are EPA-registered to kill a total of 41 different microorganisms and are formulated to be used by environmental services' professionals and around patients."

Clorox Professional Products Company contributed product for the ICHE study. Dr. Rutala and Dr. Weber are scientific consultants to Clorox.

About Clorox Professional Products Company
Clorox markets some of the most trusted and recognized brand names for healthcare settings, including Clorox®, DISPATCH® and Citrace®. These Clorox products are fast-acting, EPA-registered disinfectants intended for use by healthcare personnel on environmental surfaces and medical equipment to help reduce the spread of pathogens that cause healthcare-associated infections (HAIs). With the 2012 acquisitions of Aplicare, Inc., a leading manufacturer in the formulation, production and packaging of topical antiseptic and personal care products for healthcare settings, and HealthLink, a company dedicated to providing a wide array of medical products designed for physician's offices, the addition of these two leading providers of infection-control products expands Clorox's healthcare portfolio and reinforces the company's commitment to help stop the spread of healthcare infections. For more information, visit www.cloroxhealthcare.com.

[1] Based on 30-second bacteria and virus contact times for disinfecting on Federal master labels of leading healthcare wipes as of 10/1/11.

[2] ESKAPE claims have been registered by the Federal EPA but some may not yet be available in all 50 states.

SOURCE Clorox Professional Products Company

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.